Boulder, 80301, CO,
United States
Enveda Biosciences Technographics
Enveda Biosciences Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Enveda Biosciences and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 250 Enveda Biosciences employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Enveda Biosciences has purchased the following applications: Rippling ATS for Applicant Tracking System in 2025, Benchling Bioresearch for Laboratory Management in 2022, OpenAI GPT-4 for Generative AI Platforms in 2025 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Enveda Biosciences is running and its propensity to invest more and deepen its relationship with Rippling , Benchling , OpenAI or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Enveda Biosciences revenues, which have grown to $45.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Enveda Biosciences intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Enveda Biosciences Tech Stack and Enterprise Applications
Enveda Biosciences HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Rippling | Legacy | Rippling ATS | Applicant Tracking System | HCM | n/a | 2025 | 2025 |
|
Enveda Biosciences ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Benchling | Legacy | Benchling Bioresearch | Laboratory Management | ERP Services and Operations | n/a | 2022 | 2022 |
In 2022, Enveda Biosciences deployed Benchling Bioresearch as its centralized Laboratory Management platform to capture and structure plant characterization data for downstream machine learning. The implementation targeted fragmented experiment tracking and inconsistent data standards that were impeding Enveda's computational metabolomics workflows, and it focused on discovery and preclinical assay teams within R&D to support high-throughput chemical library generation.
Benchling Bioresearch was configured to deliver standardized experiment tracking and structured data capture, including configurable workflows, sample and assay metadata schemas, and barcode-enabled sample tracking. The implementation emphasized mapping mass spectral outputs and assay activity into consistent data models, enabling provenance, controlled vocabularies, and machine-readable records required for automated analysis.
Operationally, outputs from Benchling Bioresearch were integrated into Enveda's internal computational metabolomics platform and machine learning pipelines to create a continuous feed of curated experimental and spectral data for in silico search and lead optimization processes. The Laboratory Management deployment centralized records from bench scientists and assay teams into a unified repository, improving accessibility for data science and discovery functions.
Governance and process changes introduced standardized data capture protocols, version-controlled workflows, and experiment audit trails to enforce metadata consistency and reproducibility across teams. Post-rollout metrics recorded by Enveda indicated 66% of scientists reported a more cohesive view of experimental progress, data integrity increased by 130%, and 230% of respondents reported an average increase in speed to discovery.
|
Enveda Biosciences AI Development
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| OpenAI | Legacy | OpenAI GPT-4 | Generative AI Platforms | AI Development | n/a | 2025 | 2025 |
|
Enveda Biosciences Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Audio Video and Web Conferencing | Collaboration |
|
2023 | 2023 |
|
|
|
|
|
Collaboration | Collaboration |
|
2022 | 2022 |
|
|
|
|
|
Collaboration | Collaboration |
|
2024 | 2024 |
|
Enveda Biosciences Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Content Management | Content Management |
|
2024 | 2024 |
|
Enveda Biosciences eCommerce
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
eCommerce | eCommerce |
|
2018 | 2018 |
|
Enveda Biosciences CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Tag Management | CRM |
|
2022 | 2022 |
|
Enveda Biosciences PPM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Project Portfolio Management | PPM |
|
2025 | 2025 |
|
Enveda Biosciences PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Apps Development | PaaS |
|
2024 | 2024 |
|
|
|
|
|
Transactional Email | PaaS |
|
2024 | 2024 |
|
Enveda Biosciences IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2024 | 2024 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2023 | 2023 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2023 | 2023 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2025 | 2025 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
Enveda Biosciences CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Password Management | CyberSecurity |
|
2025 | 2025 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2025 | 2025 |
|
IT Decision Makers and Key Stakeholders at Enveda Biosciences
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Enveda Biosciences Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||